Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients
Table 4
Treatment and outcome of CMV-detected patients on the tissue at the follow-up endoscopy.
Total ()
Immunocompromised ()
Immunocompetent ()
value
Treatment
Continuation of antiviral treatments
10 (52.6%)
6 (50%)
4 (57.1%)
0.870
No further antiviral treatment/only observative treatment
9 (47.4%)
6 (50%)
3 (42.9%)
0.645
Follow-up outcome
Improvement on repeated endoscopy and histology
9 (47.4%)
5 (41.7%)
4 (57.1%)
0.730
Inhospital death
8 (42.1%)
6 (50.0%)
2 (28.6%)
0.065
No available data on follow-up/refer to other hospitals
